Patents Assigned to Novozymes, Inc.
  • Publication number: 20190055530
    Abstract: The present invention relates to isolated polypeptides having endoglucanase activity, catalytic domains, cellulose binding domains and polynucleotides encoding the polypeptides, catalytic domains or cellulose binding domains. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains or cellulose binding domains.
    Type: Application
    Filed: October 31, 2018
    Publication date: February 21, 2019
    Applicant: Novozymes, Inc.
    Inventors: Nikolaj Spodsberg, Tarana Shaghasi
  • Patent number: 10202592
    Abstract: The present invention relates to isolated polypeptides having xylanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: February 12, 2019
    Assignees: Novozymes A/S, Novozymes, Inc.
    Inventors: Elena Vlasenko, Brett McBrayer, Dominique Skovlund, Sara Landvik
  • Publication number: 20190023751
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: October 10, 2018
    Publication date: January 24, 2019
    Applicant: Novozymes, Inc.
    Inventors: Kimberly Brown, Paul Harris, Elizabeth Zaretsky, Edward Re, Elena Vlasenko, Keith McFarland, Alfredo Lopez de Leon
  • Patent number: 10179904
    Abstract: The present invention relates to isolated polypeptides having cellobiohydrolase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: January 15, 2019
    Assignee: Novozymes, Inc.
    Inventors: Marc D. Morant, Paul Harris
  • Publication number: 20190010472
    Abstract: The present invention relates to isolated polypeptides having arabinofuranosidase activity, catalytic domains, carbohydrate binding modules and polynucleotides encoding the polypeptides, catalytic domains or carbohydrate binding modules. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains or carbohydrate binding modules.
    Type: Application
    Filed: July 22, 2016
    Publication date: January 10, 2019
    Applicant: Novozymes, Inc.
    Inventors: Paul Vincent Harris, Sumati Hasani, Fang Liu
  • Publication number: 20190002858
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity, catalytic domains, cellulose binding domains and polynucleotides encoding the polypeptides, catalytic domains or cellulose binding domains. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains or cellulose binding domains.
    Type: Application
    Filed: September 6, 2018
    Publication date: January 3, 2019
    Applicants: Novozymes A/S, Novozymes, Inc.
    Inventors: Nikolaj Spodsberg, Tarana Shaghasi, Matt Sweeney, Feng Xu, Kirk Schnorr
  • Publication number: 20190002941
    Abstract: The present invention relates to recombinant filamentous fungal host cells producing cellulolytic enzyme compositions and methods of producing and using the compositions.
    Type: Application
    Filed: September 5, 2018
    Publication date: January 3, 2019
    Applicant: Novozymes, Inc.
    Inventors: Jeffrey Shasky, Suchindra Maiyuran, Amanda Fischer
  • Patent number: 10167461
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Grant
    Filed: February 22, 2016
    Date of Patent: January 1, 2019
    Assignees: Novozymes, Inc., Novozymes A/S
    Inventors: Kirk Schnorr, Randall Kramer
  • Publication number: 20180371482
    Abstract: The present invention relates to isolated polypeptides having beta-xylosidase activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Application
    Filed: August 29, 2018
    Publication date: December 27, 2018
    Applicant: Novozymes Inc.
    Inventors: Yu Zhang, Ye Liu, Junxin Duan, Lan Tang, Brett McBrayer
  • Publication number: 20180363018
    Abstract: The present invention relates to compositions comprising: a polypeptide having cellulolytic enhancing activity and a heterocyclic compound. The present invention also relates to methods of using the compositions.
    Type: Application
    Filed: August 3, 2018
    Publication date: December 20, 2018
    Applicant: Novozymes, Inc.
    Inventors: Jason Quinlan, Feng Xu, Matthew Sweeney
  • Publication number: 20180362950
    Abstract: The present invention relates to isolated polypeptides having xylanase activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Application
    Filed: September 5, 2018
    Publication date: December 20, 2018
    Applicant: Novozymes, Inc.
    Inventor: Nikolaj Spodsberg
  • Publication number: 20180355335
    Abstract: The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Application
    Filed: July 31, 2018
    Publication date: December 13, 2018
    Applicant: Novozymes Inc.
    Inventors: Yu Zhang, Ye Liu, Junxin Duan, Lan Tang
  • Publication number: 20180346948
    Abstract: The present invention relates to isolated polypeptides having catalase activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Application
    Filed: August 6, 2018
    Publication date: December 6, 2018
    Applicant: Novozymes Inc.
    Inventors: Ye Liu, Junxin Duan, Yu Zhang, Lan Tang
  • Patent number: 10144920
    Abstract: The present invention relates to variants of a parent cellobiohydrolase II. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: March 1, 2017
    Date of Patent: December 4, 2018
    Assignee: Novozymes, Inc.
    Inventor: Mark Wogulis
  • Publication number: 20180340200
    Abstract: The present invention relates to enzyme compositions comprising a polypeptide having cellobiohydrolase II activity, a polypeptide having xylanase activity, and one or more cellulolytic proteins and their use in the degradation or conversion of cellulosic material.
    Type: Application
    Filed: August 1, 2018
    Publication date: November 29, 2018
    Applicant: Novozymes, Inc.
    Inventors: Kimberly Brown, Eric Abbate
  • Patent number: 10131893
    Abstract: The present invention relates to isolated polypeptides having endoglucanase activity, catalytic domains, cellulose binding domains and polynucleotides encoding the polypeptides, catalytic domains or cellulose binding domains. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains or cellulose binding domains.
    Type: Grant
    Filed: April 25, 2017
    Date of Patent: November 20, 2018
    Assignee: Novozymes. Inc.
    Inventors: Nikolaj Spodsberg, Tarana Shaghasi
  • Publication number: 20180320155
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity and polynucleotides encoding the polypeptides, catalytic domains, cellulose binding domains and polynucleotides encoding the polypeptides, catalytic domains or cellulose binding domains. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides, catalytic domains or cellulose binding domains.
    Type: Application
    Filed: July 18, 2018
    Publication date: November 8, 2018
    Applicants: Novozymes A/S, Novozymes, Inc.
    Inventors: Kirk Schnorr, Tarana Shaghasi
  • Publication number: 20180312849
    Abstract: The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more genes selected from the group consisting of a peptaibol synthetase gene, a paracelsin synthetase gene, a first terpene cyclase gene, a second terpene cyclase gene, and a third terpene cyclase gene, wherein one or more of the genes are modified rendering the mutant strain deficient in the production of one or more of the enzymes selected from the group consisting of a peptaibol synthetase, a paracelsin synthetase, a first terpene cyclase, a second terpene cyclase, and a third terpene cyclase compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.
    Type: Application
    Filed: July 12, 2018
    Publication date: November 1, 2018
    Applicant: Novozymes, Inc.
    Inventors: Sandra Merino, Judilee Quintos, Debbie Yaver
  • Publication number: 20180305674
    Abstract: The present invention relates to isolated polypeptides having beta-xylosidase activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Application
    Filed: June 20, 2018
    Publication date: October 25, 2018
    Applicant: Novozymes, Inc.
    Inventors: Ye Liu, Lan Tang, Yu Zhang, Junxin Duan
  • Publication number: 20180298362
    Abstract: The present invention relates to isolated polypeptides having cellulolytic enhancing activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Application
    Filed: June 20, 2018
    Publication date: October 18, 2018
    Applicant: Novozymes, Inc.
    Inventors: Yu Zhang, Junxin Duan, Lan Tang